Dextromethorphan HBr 30 mg / guaiFENesin 600 mg / phenylpropanolamine HCl 37.5 mg Extended Release Oral Tablet
RxNorm 1358435
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1358435 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dextromethorphan HBr 30 mg / guaiFENesin 600 mg / phenylpropanolamine HCl 37.5 mg Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Dextromethorphan hydrobromide 30 mg / guaifenesin 600 mg / phenylpropanolamine hydrochloride 37.5 mg Extended Release Oral Tablet
(Atom ID: 12348226)
PSN
Prescribable Name (PSN):
Dextromethorphan HBr 30 mg / guaiFENesin 600 mg / phenylpropanolamine HCl 37.5 mg Extended Release Oral Tablet
(Atom ID: 6372323)
TMSY